Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-07

Clinical Trial Update: 0.05 mg Versus 0.1 mg Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy [Phase 4]

View source ↗

Summary

This Phase 4 trial compares 0.05 mg versus 0.1 mg intrathecal morphine to determine which dose better reduces postoperative morphine requirements after vaginal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)

Snippet

Sponsor: Mahidol University | Conditions: Pain | Phase 4 | Status: UNKNOWN